RXST CIK: 1111485

RxSight, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
4.52
FY22:
21.3
FY23:
53.8
FY24:
98.9
FY25:
103
(positive)
Change from FY21 to FY25
millions USD
FY21:
−52.8
FY22:
−63.3
FY23:
−50.1
FY24:
−36.9
FY25:
−48.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.7
FY22:
−57.8
FY23:
−39.3
FY24:
−23.8
FY25:
−35.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.7
FY22:
−66.7
FY23:
−48.6
FY24:
−27.4
FY25:
−38.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
−48.7
FY22:
−66.8
FY23:
−48.6
FY24:
−27.5
FY25:
−38.9

All amounts in millions USD Data sources:SEC EDGARTwelve Data